Safety Considerations in Patients Starting Immunosuppression & How to Measure RA Disease Activity | October 23, 2023
Date of Presentation: October 23, 2023
Type: Past Presentation
Audience: Clinical
Program: Rheumatoid Arthritis
Keywords: #arthritis #considerations #immuno #ra #rheaumatoid #treatment #tx
In this presentation, Dr. Jennifer Mandal reviews baseline studies and considerations prior to treating Rheumatoid Arthritis, and measuring RA disease activity.
Recording:
Presented by:
Dr. Jennifer Mandal, MD
Dr. Jennifer Mandal, MD is an Assistant Professor of Medicine at UCSF, the UCSF School of Medicine Lead for Interprofessional Education, and the Director of Evaluation for the UCSF Rheumatology Fellowship Program. Her clinical work focuses on the care of vulnerable patients with severe RA at the Rheumatoid Arthritis Clinic at Zuckerberg San Francisco General Hospital.
She has more than a decade of experience in medical education, including curriculum development, evaluation and assessment, interprofessional education research, and simulation, and has received national recognition as a leader in interprofessional health education and research. Her education research has been published in peer reviewed journals and presented nationally and internationally. Her primary interest is in utilizing novel education techniques to promote interprofessional collaboration and improve access to rheumatology care.
Resources Provided:
- To claim CE
- 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
- Safety Considerations in Patients Starting Immunosuppression & How to Measure RA Disease Activity (Presentation Slides)
- RA Diagnosis and Management One Page Guide
Date added: October 23, 2023